Apex Global Brands entered into licensing agreement with Stem Holdings, Inc. Both entities involved in the transaction are based in the US. Through this partnership, Apex Global and Stem Holdings will debut customized medically-directed CBD through licensing agreements with three of APEX's brands. First product shipments are expected to take place in early calendar year 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 USD | -80.00% | -.--% | -93.33% |
1st Jan change | Capi. | |
---|---|---|
-93.33% | 115K | |
+40.41% | 29.66B | |
-11.60% | 27.69B | |
+7.86% | 27.57B | |
+20.90% | 26.07B | |
+49.25% | 24.02B | |
+13.23% | 21.83B | |
-1.52% | 18.77B | |
+28.90% | 16.76B | |
-13.27% | 15.28B |
- Stock Market
- Equities
- STMH Stock
- News Stem Holdings, Inc.
- Apex Global Brands Inc. Signs Licensing Agreements with Stem Holdings, Inc